Striving towards the elimination of HCV infection among PWID

International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019)

Nearly 200 pages of open access articles from projects and research around the world.

While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where elimination hopes and potentials are less clear, such as in many low and middle income countries. Strengthening capacity in areas of the world where resources are more limited will be a critical step towards ensuring equity for all so that global HCV elimination among PWID can be achieved.

  • Browse articles here
  • You can also download the full issue as PDF by creating an account and signing in at the above link

Scotland’s reduction in new HCV infections is due to harm reduction, not treatment

infohep, Published:12 June 2018

The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and opioid substitution therapy, rather than a reduction in the number of people with hepatitis C as a result of increased treatment of HCV infection, a modelling study published in the journal Addiction reports.

Researchers from the University of Bristol and three Scottish universities developed a model of the Scottish HCV epidemic to test the impact of varying levels of harm reduction provision.

People who use drugs require prioritisation not exclusion in efforts to eliminate Hepatitis C

6th International Symposium on Hepatitis Care in Substance Users,  6th Sept 2017

An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them.

“The number of people around the world dying from hepatitis C is increasing. We have the tools to reverse this trend, to eliminate this disease and save millions of lives. But it will not happen until people who use drugs become a focus of our efforts,” said Associate Professor Jason Grebely, President of the International Network of Hepatitis C in Substance Users (INHSU), the convenors of the conference.